This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mazzone, T. Search for Related Content PubMed PubMed Citation Articles by Mazzone, T. Pubmed/NCBI databases Substance via MeSH Related Collections Pathophysiology Cell biology/structural biology Genetically altered mice Lipid and lipoprotein metabolism

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:2506.)
© 2000 American Heart Association, Inc.

Editorial

Scavenger Receptors in Atherosclerosis

New Answers, New Questions

Theodore Mazzone

From the Departments of Medicine and Biochemistry, Rush Medical College, Chicago, Ill.

Correspondence to Dr Theodore Mazzone, Rush Medical Center, 1653 W Congress Pkwy, Chicago, IL 60612. E-mail tmazzone@rush.edu

Key Words: Editorials • atherosclerosis • macrophages • scavenger receptors • transgenic mice

The existence of a cell surface receptor, now known as the macrophage scavenger receptor A I/II (MSR-A), was inferred from early studies based on ligand binding analyses. Description of this binding activity, with acetylated low density lipoprotein (LDL) used as a ligand, was important because it provided a mechanism for the formation of foam cells in vivo and because the activity of this receptor was not downregulated by expanding cellular cholesterol stores as had been recently shown for the LDL receptor. The presence of acetylated LDL receptor binding activity, predominantly on macrophage-type cells, helped to underscore the importance of the macrophage in atherogenesis and stimulated further investigation of macrophage function in the vessel wall. The description of this activity also helped to fuel investigative efforts to identify a potential in vivo ligand, and the various forms of oxidized LDL were soon suggested as physiological ligands for this receptor. Thus, the MSR-A has already shaped investigative efforts into the mechanisms of atherosclerosis. Now that MSR-A has been cloned, attempts to further understand its role in atherogenesis with the use of mice deficient in its expression have been undertaken.

An early report by Suzuki et al¹ demonstrated that compared with control apolipoprotein E (apoE)–knockout mice, mice with macrophage scavenger receptor A I/II (MSR-A) deficiency, on an apoE-deficient background, exhibited a 60% decrease in lesions; this observation was consistent with a proatherogenic role for this receptor in vivo. There were a number of surprising findings in their study. Even though acetylated LDL degradation . . . [Full Text of this Article]

This article has been cited by other articles:

				G. Yang, J. Addai, W.-h. Tian, A. Frolov, T. M. Wheeler, and T. C. Thompson Reduced Infiltration of Class A Scavenger Receptor Positive Antigen-Presenting Cells Is Associated with Prostate Cancer Progression Cancer Res., March 15, 2004; 64(6): 2076 - 2082. [Abstract] [Full Text] [PDF]

				R. H. Eckel, M. Wassef, A. Chait, B. Sobel, E. Barrett, G. King, M. Lopes-Virella, J. Reusch, N. Ruderman, G. Steiner, et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: Pathogenesis of Atherosclerosis in Diabetes Circulation, May 7, 2002; 105 (18): e138 - e143. [Full Text] [PDF]

				Z. H. Huang and T. Mazzone ApoE-dependent sterol efflux from macrophages is modulated by scavenger receptor class B type I expression J. Lipid Res., March 1, 2002; 43(3): 375 - 382. [Abstract] [Full Text] [PDF]